| Natalia M Irizarry, MSW | |
|
Calle Luis Pales Matos H-15, Urb. Borinquen, Cabo Rojo, PR 00623 | |
| (787) 519-9783 | |
| Not Available |
| Full Name | Natalia M Irizarry |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | Calle Luis Pales Matos H-15, Cabo Rojo, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174814974 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 10747 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Natalia M Irizarry, MSW P.o. Box 1015, Cabo Rojo, PR 00623 Ph: (787) 519-9783 | Natalia M Irizarry, MSW Calle Luis Pales Matos H-15, Urb. Borinquen, Cabo Rojo, PR 00623 Ph: (787) 519-9783 |
News Archive
Poor communication of the outcomes of medical tests whose results are pending at the time of a patient's hospital discharge is common and can lead to serious medical errors in post-hospitalization medical treatment.
When a person is sick, there is a tell-tale sign in their blood: a different mix of the various types of immune cells called leukocytes. A group of scientists at several institutions including Brown University has discovered a way to determine that mix from the DNA in archival or fresh blood samples, potentially providing a practical new technology not only for medical research but also for clinical diagnosis and treatment monitoring of ailments including some cancers.
In the first epidemiological study designed and executed specifically to determine the heart-attack risk associated with COX-2 inhibitors rofecoxib (Vioxx) and celecoxib (Celebrex), researchers at the University of Pennsylvania School of Medicine found a greater risk of heart attack associated with Vioxx than Celebrex, although neither of the two drugs showed a statistically significant elevated risk of heart attack relative to people who did not use the drugs.
Quest Diagnostics, the world's leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient's response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first test of its kind available in the United States, the test is significant because it may help physicians tailor more effective treatments for the up to 2.2 million individuals infected with HBV.
› Verified 3 days ago
Ivette Alvarez, M.A. Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Hc 1 Box 7510, Cabo Rojo, PR 00623 Phone: 787-673-7745 | |
Janice Rodriguez, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Hcol Box 7153, Cabo Rojo, PR 00623 Phone: 787-519-4678 | |
Angelica M Pagan, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 108 Calle Munoz Rivera, Cabo Rojo, PR 00623 Phone: 787-851-2025 | |
Mrs. Diana Asencio, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Hc 1 Box 8111, Cabo Rojo, PR 00623 Phone: 787-635-9937 | |
Wilda M Fernandez, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: Brau 46b St., Suite 1, Cabo Rojo, PR 00623 Phone: 787-613-5719 | |
Adela Acosta, S.W Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: G17 Calle Jose Campeche, Urb Borinquen, Cabo Rojo, PR 00623 Phone: 787-226-3380 Fax: 787-899-5141 |